532 related articles for article (PubMed ID: 25041077)
1. Maturity onset diabetes of the young in India - a distinctive mutation pattern identified through targeted next-generation sequencing.
Chapla A; Mruthyunjaya MD; Asha HS; Varghese D; Varshney M; Vasan SK; Venkatesan P; Nair V; Mathai S; Paul TV; Thomas N
Clin Endocrinol (Oxf); 2015 Apr; 82(4):533-42. PubMed ID: 25041077
[TBL] [Abstract][Full Text] [Related]
2. A family with the Arg103Pro mutation in the NEUROD1 gene detected by next-generation sequencing - Clinical characteristics of mutation carriers.
Szopa M; Ludwig-Galezowska AH; Radkowski P; Skupien J; Machlowska J; Klupa T; Wolkow P; Borowiec M; Mlynarski W; Malecki MT
Eur J Med Genet; 2016 Feb; 59(2):75-9. PubMed ID: 26773576
[TBL] [Abstract][Full Text] [Related]
3. Mutations of maturity-onset diabetes of the young (MODY) genes in Thais with early-onset type 2 diabetes mellitus.
Plengvidhya N; Boonyasrisawat W; Chongjaroen N; Jungtrakoon P; Sriussadaporn S; Vannaseang S; Banchuin N; Yenchitsomanus PT
Clin Endocrinol (Oxf); 2009 Jun; 70(6):847-53. PubMed ID: 18811724
[TBL] [Abstract][Full Text] [Related]
4. Co-inheritance of HNF1a and GCK mutations in a family with maturity-onset diabetes of the young (MODY): implications for genetic testing.
López-Garrido MP; Herranz-Antolín S; Alija-Merillas MJ; Giralt P; Escribano J
Clin Endocrinol (Oxf); 2013 Sep; 79(3):342-7. PubMed ID: 23009393
[TBL] [Abstract][Full Text] [Related]
5. Maturity onset diabetes of youth (MODY) in Turkish children: sequence analysis of 11 causative genes by next generation sequencing.
Ağladıoğlu SY; Aycan Z; Çetinkaya S; Baş VN; Önder A; Peltek Kendirci HN; Doğan H; Ceylaner S
J Pediatr Endocrinol Metab; 2016 Apr; 29(4):487-96. PubMed ID: 26669242
[TBL] [Abstract][Full Text] [Related]
6. Next generation sequencing targeted gene panel in Greek MODY patients increases diagnostic accuracy.
Tatsi EB; Kanaka-Gantenbein C; Scorilas A; Chrousos GP; Sertedaki A
Pediatr Diabetes; 2020 Feb; 21(1):28-39. PubMed ID: 31604004
[TBL] [Abstract][Full Text] [Related]
7. Low genetic confirmation rate in South Indian subjects with a clinical diagnosis of maturity-onset diabetes of the young (MODY) who underwent targeted next-generation sequencing for 13 genes.
Sampathkumar G; Valiyaparambil PP; Kumar H; Bhavani N; Nair V; Menon U; Menon A; Abraham N; Chapla A; Thomas N
J Endocrinol Invest; 2022 Mar; 45(3):607-615. PubMed ID: 34741762
[TBL] [Abstract][Full Text] [Related]
8. Genetic testing for monogenic diabetes using targeted next-generation sequencing in patients with maturity-onset diabetes of the young.
Szopa M; Ludwig-Gałęzowska A; Radkowski P; Skupień J; Zapała B; Płatek T; Klupa T; Kieć-Wilk B; Borowiec M; Młynarski W; Wołkow P; Małecki MT
Pol Arch Med Wewn; 2015; 125(11):845-51. PubMed ID: 26552609
[TBL] [Abstract][Full Text] [Related]
9. Maturity onset diabetes of the young (MODY) in Chinese children: genes and clinical phenotypes.
Ming-Qiang Z; Yang-Li D; Ke H; Wei W; Jun-Fen F; Chao-Chun Z; Guan-Ping D
J Pediatr Endocrinol Metab; 2019 Jul; 32(7):759-765. PubMed ID: 31216263
[TBL] [Abstract][Full Text] [Related]
10. The importance of combined NGS and MLPA genetic tests for differential diagnosis of maturity onset diabetes of the young.
Komazec J; Zdravkovic V; Sajic S; Jesic M; Andjelkovic M; Pavlovic S; Ugrin M
Endokrynol Pol; 2019; 70(1):28-36. PubMed ID: 30259503
[TBL] [Abstract][Full Text] [Related]
11. Identification of novel variants in the hepatocyte nuclear factor-1alpha gene in South Indian patients with maturity onset diabetes of young.
Radha V; Ek J; Anuradha S; Hansen T; Pedersen O; Mohan V
J Clin Endocrinol Metab; 2009 Jun; 94(6):1959-65. PubMed ID: 19336507
[TBL] [Abstract][Full Text] [Related]
12. Who should have genetic testing for maturity-onset diabetes of the young?
Naylor R; Philipson LH
Clin Endocrinol (Oxf); 2011 Oct; 75(4):422-6. PubMed ID: 21521318
[TBL] [Abstract][Full Text] [Related]
13. Precision Diagnosis of Maturity-Onset Diabetes of the Young with Next-Generation Sequencing: Findings from the MODY-IST Study in Adult Patients.
Aydogan HY; Gul N; Demirci DK; Mutlu U; Gulfidan G; Arga KY; Ozder A; Camli AA; Tutuncu Y; Ozturk O; Cacina C; Darendeliler F; Poyrazoglu S; Satman I
OMICS; 2022 Apr; 26(4):218-235. PubMed ID: 35333605
[TBL] [Abstract][Full Text] [Related]
14. MODY in Iceland is associated with mutations in HNF-1alpha and a novel mutation in NeuroD1.
Kristinsson SY; Thorolfsdottir ET; Talseth B; Steingrimsson E; Thorsson AV; Helgason T; Hreidarsson AB; Arngrimsson R
Diabetologia; 2001 Nov; 44(11):2098-103. PubMed ID: 11719843
[TBL] [Abstract][Full Text] [Related]
15. Molecular diagnosis of maturity-onset diabetes of the young (MODY) in Turkish children by using targeted next-generation sequencing.
Anık A; Çatlı G; Abacı A; Sarı E; Yeşilkaya E; Korkmaz HA; Demir K; Altıncık A; Tuhan HÜ; Kızıldağ S; Özkan B; Ceylaner S; Böber E
J Pediatr Endocrinol Metab; 2015 Nov; 28(11-12):1265-71. PubMed ID: 26226118
[TBL] [Abstract][Full Text] [Related]
16. Monogenic Childhood Diabetes: Dissecting Clinical Heterogeneity by Next-Generation Sequencing in Maturity-Onset Diabetes of the Young.
Demirci DK; Darendeliler F; Poyrazoglu S; Al ADK; Gul N; Tutuncu Y; Gulfidan G; Arga KY; Cacina C; Ozturk O; Aydogan HY; Satman I
OMICS; 2021 Jul; 25(7):431-449. PubMed ID: 34171966
[TBL] [Abstract][Full Text] [Related]
17. NEUROD1-deficient diabetes (MODY6): Identification of the first cases in Japanese and the clinical features.
Horikawa Y; Enya M; Mabe H; Fukushima K; Takubo N; Ohashi M; Ikeda F; Hashimoto KI; Watada H; Takeda J
Pediatr Diabetes; 2018 Mar; 19(2):236-242. PubMed ID: 28664602
[TBL] [Abstract][Full Text] [Related]
18. Targeted sequencing identifies novel variants in common and rare MODY genes.
de Santana LS; Caetano LA; Costa-Riquetto AD; Franco PC; Dotto RP; Reis AF; Weinert LS; Silveiro SP; Vendramini MF; do Prado FA; Abrahão GCP; de Almeida AGFP; Tavares MDGR; Gonçalves WRB; Santomauro Junior AC; Halpern B; Jorge AAL; Nery M; Teles MG
Mol Genet Genomic Med; 2019 Dec; 7(12):e962. PubMed ID: 31595705
[TBL] [Abstract][Full Text] [Related]
19. Targeted next-generation sequencing reveals MODY in up to 6.5% of antibody-negative diabetes cases listed in the Norwegian Childhood Diabetes Registry.
Johansson BB; Irgens HU; Molnes J; Sztromwasser P; Aukrust I; Juliusson PB; Søvik O; Levy S; Skrivarhaug T; Joner G; Molven A; Johansson S; Njølstad PR
Diabetologia; 2017 Apr; 60(4):625-635. PubMed ID: 27913849
[TBL] [Abstract][Full Text] [Related]
20. Study of ten causal genes in Turkish patients with clinically suspected maturity-onset diabetes of the young (MODY) using a targeted next-generation sequencing panel.
Doğan M; Eröz R; Bolu S; Yüce H; Gezdirici A; Arslanoğlu İ; Teralı K
Mol Biol Rep; 2022 Aug; 49(8):7483-7495. PubMed ID: 35733065
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
